Method in assaying methods involving biospecific affinity reactions and reagent for use in said method

Claim 2

In the known method of carrying out assaying methods involving biospecific affinity reactions, in which there is used a component (I) which is labelled with at least one analytically indicatable group and is soluble in the liquid in whose presence the biospecific affinity reaction is carried out, for reaction with a counterpart (II) which exhibits biospecific affinity to (I) or with said counterpart (II) and also one or more additional counterparts exhibiting biospecific affinity to at least one of (I) and (II) and forming an insoluble conjugate in which the labelled component (I) is incorporated and which conjugate is separated from the liquid phase, whereafter the analytically indicatable group is assayed in the insoluble conjugate, the improvement which comprises (A) (a) using as the analytically indicatable group one which is bound to the component (I) with a splittable bond of covalent nature, or (b) using as one of said counterparts a counterpart which is bound to a carrier, which is insoluble in said liquid, with a splittable bond of covalent nature, or (c) using as the analytically indicatable group one which is bound to the component (I) with a splittable bond of covalent nature and using as one of said counterparts a counterpart which is bound to a carrier, which is insoluble in said liquid, with a splittable bond of covalent nature, said splittable bonds, which can be the same or different, being splittable under conditions which have practically no disturbing influence on the assay method used; and (B) splitting the insoluble conjugate at said splittable bond or bonds, in the presence of a liquid, to form fragments which are soluble in said liquid and which contain the analytically indicatable group, which group is then assayed in the liquid phase.

Claim 3

A method according to claim 1, wherein said biospecific affinity reaction is an immunochemical reaction.

Claim 4

A method according to claim 1 wherein said component (I) is an immunochemical component (I).

Claim 5

A method according to claim 1, wherein said counterpart (II) is an immunochemical counterpart (II).

Claim 6

A method according to claim 1 wherein an immunochemical counterpart is involved as said at least one additional counterparts.

Claim 7

A method according to claim 1 wherein the analytically indicatable group is an enzymatically active group.

Claim 8

A method according to claim 1 wherein the analytically indicatable group is an enzymatically active group or a fluroescent group, said group comprising the only part of the conjugate being bound with the splittable bond.

Claim 9

A method according to claim 1, or 5, or 6, wherein the splittable bond is a disulphide bond --S--S--.

Claim 10

A method according to claim 1, or 5, or 6, wherein the splittable bond is an enzymatically splittable bond.

Claim 11

In the known method of carrying out assaying methods involving biospecific affinity reactions, in which there is used a component (I), which is labelled with at least one analytically indicatable group and is soluble in the liquid in whose presence the biospecific affinity reaction is carried out, for reaction with a counterpart (II) which exhibits biospecific affinity to (I) or with said counterpart (II) and also one or more additional counterparts exhibiting biospecific affinity to at least one of (I) and (II) and forming an insoluble conjugate in which the labelled component (I) is incorporated and which conjugate is separated from the liquid phase, whereafter the analytically indicatable group is assayed in the insoluble conjugate, the improvement which comprises (A) (a) using as the analytically indicatable group one which is bound to the component (I) with a splittable bond of covalent nature, or (b) using as one of said counterparts a counterpart which is bound to a carrier, which is insoluble in said liquid, with a splittable bond of covalent nature, or (c) as the analytically indicatable group one which is bound to the component (I) with a splittable bond of covalent nature and as one of said counterparts a counterpart which is bound to a carrier which is insoluble in said liquid, with a splittable bond of covalent nature, said splittable bonds, which can be the same or different, being splittable under conditions which have practically no disturbing influence on the assay method used and said labelled component (I) comprising a multi-conjugate of a plurality of analytically indicatable groups linked together via linkages containing splittable bonds, said multiconjugate of indicatable groups in turn being bound to the component (I); and (B) splitting the insoluble conjugate at said splittable bond or bonds, in the presence of a liquid, to form fragments which are soluble in said liquid and which contain the analytically indicatable group, which group is then assayed in the liquid phase.

Claim 12

In the known method of carrying out assaying methods involving biospecific affinity reactions, in which there is used a component (I), which is labelled with at least one analytically indicatable group and is soluble in the liquid in whose presence the biospecific affinity reaction is carried out, for reaction with a counterpart (II) which exhibits biospecific affinity to (I) or with said counterpart (II) and also one or more additional counterparts exhibiting biospecific affinity to at least one of (I) and (II) and forming an insoluble conjugate in which the labelled component (I) is incorporated and which conjugate is separated from the liquid phase, whereafter the analytically indicatable group is assayed in the insoluble conjugate, the improvement which comprises (A) (a) using as the analytically indicatable group one which is bound to the component (I) with a splittable bond of covalent nature, or (b) using as one of said counterparts a counterpart which is bound to a carrier, which is insoluble in said liquid, with a splittable bond of covalent nature, or (c) as the analytically indicatable group one which is bound to the component (I) with a splittable bond of covalent nature and as one of said counterparts a counterpart which is bound to a carrier which is insoluble in said liquid, with a splittable bond of covalent nature, said splittable bonds, which can be the same or different, being splittable under conditions which have practically no disturbing influence on the assay method used and said labelled component (I) comprising a multi-conjugate of a plurality of analytically indicatable groups linked together via linkages containing splittable bonds, said multiconjugate of indicatable groups in turn being bound to the component (I); and (B) splitting the insoluble conjugate at said splittable bond or bonds, in the presence of a liquid, to form fragments which are soluble in said liquid and which contain the analytically indicatable group, which group is then assayed in the liquid phase.

Claim 13

A method according to claim 10 wherein said biospecific affinity reaction is an immunochemical reaction.

Claim 14

A method according to claim 10 wherein said component (I) is an immunochemical component (I).

Claim 15

A method according to claim 10 wherein said counterpart (II) is an immunochemical counterpart (II).

Claim 16

A method according to claim 10 wherein an immunochemical counterpart is involved as said at least one additional counterpart.

Claim 17

A method according to claim 10 wherein the analytically indicatable group is an enzymatically active group.

Claim 18

A method according to claim 10 wherein the analytically indicatable group is an enzymatically active group or a fluorescent group, said group comprising the only part of the conjugate being bound with the splittable bond.

Claim 19

A method according to claim 10, 15 or 16, wherein the splittable bond is a disulphate bond --S--S--.

Claim 20

A method according to claim 10, or 15, or 16 wherein the splittable bond is an enzymatically splittable bond.

Claim 21

A reagent for use in assaying methods involving biospecific affinity reactions which reagent comprises a labelled immunochemical component (I) comprising a multi-conjugate of a plurality of analytically indicatable groups linked together via linkages containing splittable covalent bonds, said multiconjugate of indicatable groups in turn being bound to the immunochemical component.

Claim 22

A reagent for use in assaying methods involving biospecific affinity reactions which reagent comprises a labelled immunochemical component (I) comprising a multi-conjugate of a plurality of analytically indicatable groups linked together via linkages containing splittable covalent bonds, said multiconjugate of indicatable groups in turn being bound to the immunochemical component.

Claim 23

A reagent according to claim 19 wherein the splittable bond is a disulphide bond --S--S--.